London-Based Biotech Baccuico Announces $3.8M Seed Round And Name Change To Bactobio
Oct 06, 2021•almost 4 years ago
Amount Raised
$3.8 Million
Round Type
seed
Description
Baccuico, a London-based biotechnology company, has completed a $3.8M seed round to support their mission to discover novel solutions from previously unculturable soil bacteria. With this round, Baccuico builds on an already stellar network of investors acting as advisors - including Peder Holk Nielsen (Former CEO & President, Novozymes), Leopoldo Zambeletti (Former Head of Healthcare, JP Morgan), Jonathan Milner (Founder, Abcam) and Claudio Costamagna (Former Chairman, Goldman Sachs (EMEA)) - with expertise in the agritech sector through the addition of Hugh Grant (Former Chairman & CEO, Monsanto).